跳至主要内容
临床试验/NCT04969081
NCT04969081已完成不适用

Augmenting Early Phase Substance Use Treatment With Therapeutic Work Activity to Improve Clinical Outcomes: a New Indication for an Old Intervention

VA Office of Research and Development1 个研究点 分布在 1 个国家目标入组 103 人开始时间: 2022年1月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
103
试验地点
1
主要终点
percent days abstinent

研究概览

简要总结

To date, there are no studies of the therapeutic effects of varied work-focused programs in Veterans undergoing outpatient substance use disorder (SUD) treatment. The investigators propose a randomized clinical trial to test the effects of work-focused programs on improving sobriety and other clinical outcomes in Veterans early in the course of recovery from SUD. Veterans will be randomized to either receive or not receive referral for work-focused therapeutic programs. Primary aim is to examine effects of work-focused programs on sobriety outcomes, namely sobriety and global functioning. Secondary aim is to examine effects of work-focused programs on psychiatric symptoms, self esteem/efficacy, and quality of life.

详细描述

The investigators propose a trial to test the effects of Incentive Therapy (IT) and Other Therapeutic and Supported Employment Services (Other TSES) on improving SUD outcomes in newly recovering Veterans in outpatient treatment. In line with eligibility criteria for different TSES programs, the investigators will employ a two branch study: One branch will be for Veterans who are not interested in pursuing competitive employment, and will be a two arm RCT with randomization (2:1) to referral for IT + treatment as usual (TAU; including usual SUD outpatient treatment) or TAU alone. The second branch will be for Veterans who express interest in competitive employment, and will be a two arm Randomized Controlled Trial (RCT) with randomization (2:1) to referral for TSES competitive employment services + TAU or TAU alone. Total Intent to Treat sample will be 140 (n=70 per branch). Primary outcomes will be percent days abstinent during 3 month active phase and clinical global impression scale scores at 6 months. Secondary outcome will be psychiatric symptoms, self esteem/efficacy and quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Assessors will be blind to randomization status.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Participants will be Veterans enrolled in VACHS substance use treatment, who at time of consenting into the study are within 30 days of detoxification or last substance use as per medical record.
  • •Additional criteria will be as follows:
  • •Meeting DSM-V criteria for any current Substance Use Disorder (SUD) (e.g., opioids, cocaine, marijuana, amphetamine, or alcohol)
  • •Competent to give written informed consent and HIPAA authorization

排除标准

  • •Involvement in a legal case that may lead to incarceration during study period
  • •Developmental disability or medical illness that would prevent therapeutic work activity, as judged by PI or clinical staff providing this service
  • •Plans to relocate outside geographic area that would make follow-up unlikely
  • •And/or lack of willingness to provide contact information of someone who can help us contact the participant in the event that the investigators are unable to maintain contact directly

研究组 & 干预措施

treatment as usual plus referral to work focused program

Experimental

usual substance use treatment plus referral to a competitive or non-competitive work-focused program

干预措施: referral to work focused program (Behavioral)

treatment as usual

Active Comparator

usual substance use treatment

干预措施: treatment as usual (Other)

treatment as usual plus referral to work focused program

Experimental

usual substance use treatment plus referral to a competitive or non-competitive work-focused program

干预措施: treatment as usual (Other)

结局指标

主要结局

percent days abstinent

时间窗: 3 months

percent days abstinent during 3-month active phase

Clinical Global Impression

时间窗: 6 months

Clinical Global Impression ratings conducted at 6 months from study entry.

次要结局

  • change from baseline in New General Self-Efficacy Scale(6 months)
  • change in WHOQOL BREF(6 months)
  • change from baseline in BASIS-24(3 months)
  • change from baseline in Rosenberg self-esteem scale(6 months)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验